Northwestern Mutual Wealth Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.28K Buy
+28
New +$2.81K ﹤0.01% 3528
2025
Q1
– Sell
-9
Closed -$372 – 3838
2024
Q4
$372 Sell
9
-7
-44% -$292 ﹤0.01% 3408
2024
Q3
$624 Buy
+16
New +$638 ﹤0.01% 3313
2023
Q3
– Sell
-785
Closed -$20.3K – 3446
2023
Q2
$20.3K Buy
+785
New +$20.9K ﹤0.01% 2308

Other funds holding MIRM

Northwestern Mutual Wealth Management's MIRM Position: Q2 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 28 shares worth $3.28K. The stake represents ﹤0.01% of the portfolio and ranks #3528 among its holdings. This is a return to the name: Northwestern Mutual Wealth Management previously reported a position in MIRM as recently as Q4 2024.

Northwestern Mutual Wealth Management first reported a position in MIRM in Q2 2023 and has held it in 4 quarters since. The position peaked at $20.3K in Q2 2023. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Northwestern Mutual Wealth Management held 28 shares of Mirum Pharmaceuticals worth $3.28K as of Q2 2026.
  • Mirum Pharmaceuticals was a new Northwestern Mutual Wealth Management position in Q2 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3528 holding.
  • Northwestern Mutual Wealth Management first reported a position in Mirum Pharmaceuticals in Q2 2023 and has held it in 4 quarters since.
  • Northwestern Mutual Wealth Management's Mirum Pharmaceuticals position peaked at $20.3K in Q2 2023.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.